Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep31: Treating Disease Progression with DTx: Dr. Mark Berman Shares Insights on Innovative Prescription Digital Therapeutics

Ep31: Treating Disease Progression with DTx: Dr. Mark Berman Shares Insights on Innovative Prescription Digital Therapeutics

FromDTx Podcast with Eugene Borukhovich


Ep31: Treating Disease Progression with DTx: Dr. Mark Berman Shares Insights on Innovative Prescription Digital Therapeutics

FromDTx Podcast with Eugene Borukhovich

ratings:
Length:
40 minutes
Released:
Jun 30, 2022
Format:
Podcast episode

Description

Cognitive behavioral therapy (CBT) is an evidence-based form of therapy that has been in use for decades. My guest in this episode believes that CBT can be applied to create better therapeutics, and, in fact, that's exactly what his company is called: Better Therapeutics.

Dr. Mark Berman, the Chief Medical Officer at Better Therapeutics, explained that the goal of CBT is to "help people change some of those core beliefs, which then directly influence what we do on a day to day basis."

And while CBT was originally applied to help people with conditions like PTSD, anxiety and depression, the team at Better Therapeutics have developed their own variant of CBT to apply the core principles of CBT to the ideas that drive root behaviors like diet, exercise and other supportive lifestyle behaviors.

Tune into this episode to hear how Better Therapeutics are creating new digital treatments to reverse the progression of cardiometabolic disease, improve quality of life and inform clinical decisions.

In this episode, we cover:

Patient experience using digital therapeutics for type 2 diabetes

Nutritional CBT - Better Therapeutics innovative new form of Cognitive Behavioral Therapy

Why companies are opting to create Prescription Digital Therapies rather than self-managed lifestyle apps

What’s next in the Better Therapeutics pipeline and how these decisions are made

The future of Digital Therapeutic infrastructure


Guest Links and Resources:

Connect with Mark Berman on LinkedIn | Twitter


Visit bettertx.com



Episode Mentions:

Kevin Appelbaum - founder of Better TX: LinkedIn


Margaret Moore - Founder & CEO Wellcoaches Corporation: LinkedIn



Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Released:
Jun 30, 2022
Format:
Podcast episode

Titles in the series (100)

Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.